Previous Article | Next Article 
Infection and Immunity, April 2002, p. 2057-2064, Vol. 70, No. 4
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.4.2057-2064.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Lipoteichoic Acids from Lactobacillus johnsonii Strain La1 and Lactobacillus acidophilus Strain La10 Antagonize the Responsiveness of Human Intestinal Epithelial HT29 Cells to Lipopolysaccharide and Gram-Negative Bacteria
Karine Vidal,1* Anne Donnet-Hughes,1 and Dominique Granato2
Food Immunology Group,1
Digestive Health Group, Nestlé Research Center, Nestec Limited, Vers-chez-les-Blanc, Lausanne, Switzerland2
Received 2 October 2001/
Returned for modification 1 November 2001/
Accepted 21 December 2001
Intestinal epithelial cells (IECs) respond to lipopolysaccharide (LPS) from gram-negative bacteria in the presence of the soluble form of CD14 (sCD14), a major endotoxin receptor. Since sCD14 is also known to interact with gram-positive bacteria and their components, we looked at whether sCD14 could mediate their effects on human IECs. To this end, we examined the production of proinflammatory cytokines following exposure of the IECs to specific gram-positive bacteria or their lipoteichoic acids (LTAs) in the absence and presence of human milk as a source of sCD14. In contrast to LPS from Escherichia coli or Salmonella enteritidis, neither the gram-positive bacteria Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 nor their LTAs stimulated IECs, even in the presence of sCD14. However, both LTAs inhibited the sCD14-mediated LPS responsiveness of IECs. We have previously hypothesized that sCD14 in human milk is a means by which the neonate gauges the bacterial load in the intestinal lumen and liberates protective proinflammatory cytokines from IECs. The present observations suggest that gram-positive organisms, via their LTAs, temper this response and prevent an exaggerated inflammatory response.
* Corresponding author. Mailing address: Food Immunology Group, Nestec Limited, Nestlé Research Center, Vers-chez-les-Blanc, P.O. Box 44, CH-1000 Lausanne 26, Switzerland. Phone: 41 21 785 82 65. Fax: 41 21 785 89 25. E-mail:
karine.vidal{at}rdls.nestle.com.
Editor: E. I. Tuomanen
Infection and Immunity, April 2002, p. 2057-2064, Vol. 70, No. 4
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.4.2057-2064.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lebeer, S., Vanderleyden, J., De Keersmaecker, S. C. J.
(2008). Genes and Molecules of Lactobacilli Supporting Probiotic Action. Microbiol. Mol. Biol. Rev.
72: 728-764
[Abstract]
[Full Text]
-
Winkler, P., Ghadimi, D., Schrezenmeir, J., Kraehenbuhl, J.-P.
(2007). Molecular and Cellular Basis of Microflora-Host Interactions. J. Nutr.
137: 756S-772S
[Abstract]
[Full Text]
-
Perez, P. F., Dore, J., Leclerc, M., Levenez, F., Benyacoub, J., Serrant, P., Segura-Roggero, I., Schiffrin, E. J., Donnet-Hughes, A.
(2007). Bacterial Imprinting of the Neonatal Immune System: Lessons From Maternal Cells?. Pediatrics
119: e724-e732
[Abstract]
[Full Text]
-
Bergonzelli, G. E., Granato, D., Pridmore, R. D., Marvin-Guy, L. F., Donnicola, D., Corthesy-Theulaz, I. E.
(2006). GroEL of Lactobacillus johnsonii La1 (NCC 533) Is Cell Surface Associated: Potential Role in Interactions with the Host and the Gastric Pathogen Helicobacter pylori. Infect. Immun.
74: 425-434
[Abstract]
[Full Text]
-
Sgouras, D. N., Panayotopoulou, E. G., Martinez-Gonzalez, B., Petraki, K., Michopoulos, S., Mentis, A.
(2005). Lactobacillus johnsonii La1 Attenuates Helicobacter pylori-Associated Gastritis and Reduces Levels of Proinflammatory Chemokines in C57BL/6 Mice. CVI
12: 1378-1386
[Abstract]
[Full Text]
-
Altermann, E., Russell, W. M., Azcarate-Peril, M. A., Barrangou, R., Buck, B. L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., Lick, S., Hamrick, A., Cano, R., Klaenhammer, T. R.
(2005). Inaugural Article: From the Cover: Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc. Natl. Acad. Sci. USA
102: 3906-3912
[Abstract]
[Full Text]
-
Granato, D., Bergonzelli, G. E., Pridmore, R. D., Marvin, L., Rouvet, M., Corthesy-Theulaz, I. E.
(2004). Cell Surface-Associated Elongation Factor Tu Mediates the Attachment of Lactobacillus johnsonii NCC533 (La1) to Human Intestinal Cells and Mucins. Infect. Immun.
72: 2160-2169
[Abstract]
[Full Text]
-
Reid, G., Jass, J., Sebulsky, M. T., McCormick, J. K.
(2003). Potential Uses of Probiotics in Clinical Practice. Clin. Microbiol. Rev.
16: 658-672
[Abstract]
[Full Text]
-
Engels-Deutsch, M., Pini, A., Yamashita, Y., Shibata, Y., Haikel, Y., Scholler-Guinard, M., Klein, J.-P.
(2003). Insertional Inactivation of pac and rmlB Genes Reduces the Release of Tumor Necrosis Factor Alpha, Interleukin-6, and Interleukin-8 Induced by Streptococcus mutans in Monocytic, Dental Pulp, and Periodontal Ligament Cells. Infect. Immun.
71: 5169-5177
[Abstract]
[Full Text]